Market Overview

Benzinga's Top Upgrades, Downgrades For September 7, 2018

Share:

Top Upgrades

  • Bank of America upgraded AK Steel Holding Corporation (NYSE: AKS) from Underperform to Buy. AK Steel shares rose 2.36 percent to $4.33 in pre-market trading.
  • Argus upgraded Southwest Airlines Co (NYSE: LUV) from Hold to Buy. Southwest shares rose 0.77 percent to $61.50 in pre-market trading.
  • Jefferies upgraded Vale SA (ADR) (NYSE: VALE) from Hold to Buy. Vale shares rose 2.08 percent to $13.26 in pre-market trading.
  • SunTrust Robinson Humphrey upgraded Centennial Resource Development Inc (NASDAQ: CDEV) from Hold to Buy. Centennial Resource Development shares fell 0.99 percent to close at $18.94 on Thusrday.

 

Top Downgrades

  • Macquarie downgraded Wells Fargo & Co (NYSE: WFC) from Outperform to Neutral. Wells Fargo shares fell 0.59 percent to $57.59 in pre-market trading.
  • Deutsche Bank downgraded T. Rowe Price Group Inc (NASDAQ: TROW) from Buy to Hold. T. Rowe Price shares fell 1.2 percent to $111.90 in pre-market trading.
  • SunTrust Robinson Humphrey downgraded Cimarex Energy Co (NYSE: XEC) from Buy to Hold. Cimarex Energy shares fell 0.77 percent to close at $85.47 on Thursday.
  • BMO Capital downgraded Dover Corp (NYSE: DOV) from Outperform to Market Perform. Dover shares fell 0.39 percent to $86.00 in pre-market trading.
  • Raymond James downgraded Core-Mark Holding Company, Inc. (NASDAQ: CORE) from Strong Buy to Outperform. Core-Mark shares rose 1.01 percent to close at $36.96 on Thursday.

 

Top Initiations

  • B. Riley FBR initiated coverage on Audentes Therapeutics Inc (NASDAQ: BOLD) with a Sell rating. The price target for Audentes Therapeutics is set to $20. Audentes Therapeutics shares closed at $37.09 on Thursday.
  • Cantor Fitzgerald initiated coverage on Tabula Rasa HealthCare Inc (NASDAQ: TRHC) with an Overweight rating. The price target for Tabula Rasa HealthCare is set to $99. Tabula Rasa HealthCare shares closed at $83.95 on Thursday.
  • Mizuho initiated Unity Biotechnology Inc (NASDAQ: UBX) with a Buy rating. The price target for Unity Biotechnology is set to $33. Unity Biotechnology shares closed at $18.02 on Thursday.
  • Analysts at B. Riley FBR initiated coverage on Homology Medicines Inc (NASDAQ: FIXX) with a Neutral rating. The price target for Homology Medicines is set to $18.50. Homology Medicines shares closed at $15.96 on Thursday.
  • Cantor Fitzgerald initiated coverage on Menlo Therapeutics Inc (NASDAQ: MNLO) with an Overweight rating. The price target for Menlo Therapeutics is set to $25. Menlo Therapeutics shares closed at $7.63 on Thursday.
  • Analysts at B. Riley FBR initiated coverage on Zogenix, Inc. (NASDAQ: ZGNX) with a Buy rating. The price target for Zogenix is set to $116. Zogenix shares closed at $45.65 on Thursday.
  • Oppenheimer initiated coverage on Caterpillar (NYSE: CAT) with a Neutral rating. Caterpillar shares closed at $141.57 on Thursday.
  • Raymond James initiated coverage on Trupanion Inc (NASDAQ: TRUP) with an Outperform rating. The price target for Trupanion is set to $46. Trupanion shares closed at $37.37 on Thursday.
 

Related Articles (AKS + BOLD)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
VLDRCraig-HallumInitiates Coverage On23.0
MFACNorthland Capital MarketsInitiates Coverage On15.0
CEREJefferiesInitiates Coverage On18.0
GIIIUBSInitiates Coverage On22.0
LESLWilliam BlairInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com